In the heart of 9th century Morocco, a woman quietly rewrote the future of global education. She was Fatima al-Fihri and she ...

An independent Data Safety Monitoring Board (DSMB) has recommended the continuation of BioCardia's Phase I/II CardiALLO-HF ...

Emory University School of Medicine, US, has commenced subject enrolment for BioCardia’s Phase III CardiAMP HF II trial.

There’s nothing quite like the delicious drama of General Hospital, a place where love triangles have more twists than a double helix, people come back from the dead like it’s a casual Tuesday, and co ...

About CardiALLO HF The CardiALLO Heart Failure Trial is a Phase I/II study with an open label Phase I nine-patient dose escalation cohort, followed by a thirty-patient randomized double-blinded ...

Is Rosalind Franklin a ghost that still haunts the history of genomic science? Alan Booth looks into her remarkable story ...

To celebrate the 30th edition of the L.A. Times Festival of Books, we asked authors, editors, critics and scholars to select ...

CardiAMP HF II is Evaluating the CardiAMP™ Cell Therapy Product for Treating Patients with Ischemic Heart Failure of Reduced Ejection Fraction ...

The obvious draw to McCall is the skiing. The small town sits in the Cuddy and Salmon River Mountains of Idaho, collecting ...

From pixel art and chemistry, to robotics and storytelling, the Sharjah Children’s Reading Festival (SCRF 2025) is back with ...